Thomas Egger
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Co-authors
- Daniel Betticher (7 shared papers)Joëlle Leonie Flueck (1 shared paper)A. von Rohr (3 shared papers)Martin F. Fey (2 shared papers)S.‐F. Hsu Schmitz (2 shared papers)Daniel Ratschiller (2 shared papers)T. Cerny (1 shared paper)T. Cerny (2 shared papers)
- Journals
- Nutrients (1 paper)British Journal of Haematology (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)JMIR Public Health and Surveillance (1 paper)Annals of Oncology (1 paper)
- Partner nations
- SwitzerlandUnited KingdomAustria
In The Last Decade
Thomas Egger
16 papers receiving 215 citations
Peers
Comparison fields: 5 of 68
- Genetics 78
- Pathology and Forensic Medicine 83
- Hematology 43
- Oncology 82
- Infectious Diseases 40
Countries citing papers authored by Thomas Egger
This map shows the geographic impact of Thomas Egger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Egger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Egger more than expected).
Fields of papers citing papers by Thomas Egger
This network shows the impact of papers produced by Thomas Egger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Egger. The network helps show where Thomas Egger may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Egger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 37 | |
| 2 | 1995 | 35 | |
| 3 | 2016 | 25 | |
| 4 | 1998 | 23 | |
| 5 | 1987 | 22 | |
| 6 | 2020 | 20 | |
| 7 | 1996 | 17 | |
| 8 | 2018 | 10 | |
| 9 | 2015 | 8 | |
| 10 | Stainable bone iron in undecalcified, plastic-embedded sections. Occurrence in man related to the presence of "free" iron? | 1988 | 7 |
| 11 | 1981 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2004 | 3 | |
| 14 | 2014 | 2 | |
| 15 | 1983 | 1 | |
| 16 | 2020 | 1 |
About Thomas Egger
Thomas Egger is a scholar working on Oncology, Genetics, Epidemiology, Hematology and Surgery, having authored 16 papers that have together received 223 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (2 papers), COVID-19 diagnosis using AI (1 paper), Quality and Supply Management (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Genetics (78 citations), Pathology and Forensic Medicine (83 citations), Hematology (43 citations), Oncology (82 citations) and Infectious Diseases (40 citations). Thomas Egger has collaborated with scholars based in Switzerland, United Kingdom and Austria. Frequent co-authors include Daniel Betticher, Joëlle Leonie Flueck, A. von Rohr, Martin F. Fey, S.‐F. Hsu Schmitz, Daniel Ratschiller, T. Cerny, T. Cerny, Helmut Gruber and Martin F. Lischka. Their work appears in journals such as Nutrients, British Journal of Haematology, Journal of Antimicrobial Chemotherapy, JMIR Public Health and Surveillance and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.